A second defendant has joined in the effort to disqualify Motley Rice from dozens of opioid cases, citing “newly discovered evidence.”

Express Scripts Inc., a pharmacy benefit manager facing upcoming bellwether trials over the opioid crisis, filed a March 13 brief referencing a subpoena that Motley Rice member Linda Singer, then at Cohen Milstein Sellers & Toll, sent to the company on behalf of the city of Chicago.